Management of Routine Surgery in Diabetes

  • Sanjeev Kelkar
  • Shubhangi Muley
  • Prakash Ambardekar


Routine or elective minor and major surgery in diabetes must be taken equally seriously as the emergency surgery, in each and every aspect related to it. In emergency surgery, each stakeholder is prepared for a certain element of adverse or untoward happening. There is no guarantee that something similar may not happen in the elective cases, be it minor or major surgery, a distinction between the two made below. If it does happen it reflects extremely adversely over all those involved in the process, the hospital set up and can result in unseemly incidents which can undermine the morale of all concerned. In particular, explanation and documentation of the risk factors and the percentage possibility that it can happen in the said elective surgery would be the paramount, among other factors of care.


  1. 1.
    Australian Diabetes Society. Peri-operative diabetes management guidelines, July 2012, ADS working group of Vincent Wong, Glynis Ross, Jennifer Wong and David Chipps (chair).Google Scholar
  2. 2.
    Kelkar SK. Observations on office staff in a remote thermal electric power plant MP India; 1997.Google Scholar
  3. 3.
    Guillermo U, Umpierrez E, Smiley D, Jacobs S, Peng L, Temponi A, Mulligan P, Umpierrez D, Newton C, Olson D, Rizzo M. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care. 2011;34:256–61.CrossRefGoogle Scholar
  4. 4.
    UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–53.CrossRefGoogle Scholar
  5. 5.
    The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–86.CrossRefGoogle Scholar
  6. 6.
    Dluhy RG, McMahon GT. Intensive glycemic control in the ACCORD and ADVANCE trials. N Engl J Med. 2008;358:2630–3.CrossRefGoogle Scholar
  7. 7.
    Little RR, Rohlfing CL. The long and winding road to optimal HbA1c measurement. Clin Chim Acta. 2013;418:63–71.CrossRefGoogle Scholar
  8. 8.
    Lindholm P, Minn H, Leskinen-Kallio S, Bergman J, Ruotsalainen U, Joensuu H. Influence of the blood glucose concentration on FDG uptake in cancer – a PET study. J Nucl Med. 1993;34(1):6–11.Google Scholar
  9. 9.
    Ishizu K, Nishizawa S, Yonekura Y, Sadato N, Magata Y, Tamaki N, Tsuchida T, Okazawa H, Miyatake S, Ishikawa M. Effects of hyperglycemia on FDG uptake in human brain and glioma. J Nucl Med. 1994;35(7):1104–9.PubMedGoogle Scholar
  10. 10.
    Zhuang HM, Cortes-Blanco A, Pourdehnad M, Adam LE, Yamamoto AJ, Martinez-Lazaro R, Lee JH, Loman JC, Rossman MD, Alavi A. Do high glucose levels have differential effect on FDG uptake in inflammatory and malignant disorders? Nucl Med Commun. 2001;22(10):1123–8.CrossRefGoogle Scholar
  11. 11.
    Mears SC, Lipsett PA, Brager MD, Riley LH III. Metformin-associated lactic acidosis after elective cervical spine fusion: a case report. Spine. 2002;27(22):E482–4.CrossRefGoogle Scholar
  12. 12.
    Mercker SK, Maier C, Neumann G, Wulf H. Lactic acidosis as a serious perioperative complication of antidiabetic biguanide medication with metformin. Anesthesiology. 1997;87(4):1003–5.CrossRefGoogle Scholar
  13. 13.
    Chan NN, Feher MD. Metformin and perioperative risk. Br J Anaesth. 1999;83(3):540–1.CrossRefGoogle Scholar
  14. 14.
    Bailey CJ, Turner RC. Metformin. N Engl J Med. 1996;334(9):574–9.CrossRefGoogle Scholar
  15. 15.
    Thomsen HS, Morcos SK. Contrast media and metformin: guidelines to diminish the risk of lactic acidosis in non-insulin-dependent diabetics after administration of contrast media. ESUR Contrast Media Safety Committee. Eur Radiol. 1999;9(4):738–40.CrossRefGoogle Scholar
  16. 16.
    Jamet P, Lebas de Lacour JC, Christoforov B, Stern M. Fatal case of metformin-induced lactic acidosis after urography in a diabetic patient. Sem Hop. 1980;56(9–10):473–4.PubMedGoogle Scholar
  17. 17.
    Klow NE, Draganov B, Os I. Metformin and contrast media—increased risk of lactic acidosis? Tidsskr Nor Laegeforen. 2001;121(15):1829.PubMedGoogle Scholar
  18. 18.
    McCartney MM, Gilbert FJ, Murchison LE, Pearson D, McHardy K, Murray AD. Metformin and contrast media—a dangerous combination? Clin Radiol. 1999;54(1):29–33.CrossRefGoogle Scholar
  19. 19.
    Joslin EP. Joslin’s textbook of diabetes mellitus. 14th ed. Lippincott, Williams and Wilkins, USA 2005, Indian Edition.Google Scholar
  20. 20.
    Pareek A, et al. Efficacy and safety of hydroxychloroquine in the treatment of type 2 diabetes mellitus: a double blind, randomized comparison with pioglitazone. Curr Med Res Opin. 2014;30(7):1257–66.CrossRefGoogle Scholar
  21. 21.
    Quatraro A, Consoli G, Magno M, et al. Hydroxychloroquine in decompensated, treatment-refractory noninsulin-dependent diabetes mellitus: a new job for an old drug? Ann Intern Med. 1990;112:678–81.CrossRefGoogle Scholar
  22. 22.
    Krentz A, Bailey C. Oral anti-diabetic agents: current role in type 2 diabetes mellitus. Drugs. 2006;65:385–411.CrossRefGoogle Scholar
  23. 23.
    Fessler B, Alarcon G, McGwin G, et al. Systemic lupus erythematosus in three ethnic groups: XVI. Association of hydroxychloroquine use with reduced risk of damage accrual. Arthritis Rheum. 2005;52:1473–80.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  • Sanjeev Kelkar
    • 1
  • Shubhangi Muley
    • 2
  • Prakash Ambardekar
    • 3
  1. 1.Private PracticePuneIndia
  2. 2.Senior Consultant AnesthesiologistCentral India Institute of Medical ScienceNagpurIndia
  3. 3.Consultant, AnesthesioligistFortis S L Raheja HospitalMumbaiIndia

Personalised recommendations